Introduction Acceptable Intake (AI) Limits for Nitrosamines Calculation is performed through linear low-dose extrapolation using rodent TD50 carcinogenicity bioassays or […]
Introduction: Nitrosamine root cause investigation for injectable drugs is a critical analytical and pharmaceutical-development activity whenever a nitrosamine impurity is
Introduction A comprehensive Nitrosamine Risk Assessment for a Proton Pump Inhibitor seeking Abbreviated New Drug Application (ANDA) approval requires a
Introduction NDSRI Quantification at Ultra-Low Levels requires advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodologies capable of detecting mutagenic impurities at
Introduction: Nitrosamine Risk Assessment for Combination Oral Solid Dosage Forms is particularly important when a pharmaceutical product contains two or
Introduction Nitrosamine Leachables Testing is a comprehensive analytical and regulatory process used to evaluate pharmaceutical packaging and drug delivery systems
Nitrosamine Leachables Testing: From Risk Assessment to Confirmatory LC-MS/MS Analysis Read More »
Introduction Nitrosamine Testing for Antidepressants and SSRIs is a specialized analytical and regulatory process designed to detect, quantify, and control
Introduction Headspace GC-MS for Volatile Nitrosamine Analysis is a sophisticated and highly selective analytical technique widely employed to identify and
Introduction Nitrosamine Testing for Antibiotics and Beta-Lactam APIs is a specialized analytical mandate focused on the detection, identification, and quantification
Introduction: Nitrosamine Root Cause Investigation for Sartan APIs has become a defining requirement across pharmaceutical manufacturing following the global recalls
